Lipase Reagent, 7D80. Used to measure lipase in human serum on the Architect system.
Published November 5, 2014 · Recall initiated: April 7, 2014
Summary
FDA records medical device Class II recall Z-0131-2015, published November 5, 2014 and initiated April 7, 2014. Recalling firm: Abbott Laboratories, Inc; Status: Terminated; Reported quantity: 11916 units; Lot: lots 43827UQ12, 43819UQ03, 44449UQ05, 44127UQ06, 44334UQ07, 43994UQ07, 44596UQ08, 44775UQ09, and 44930UQ11. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Package inserts have incorrect SmartWash parameters for Triglyceride.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Laboratories, Inc
- Distributor
- Worldwide Distribution: US (nationwide) and countries of: Algeria, Angola, Argentina, Armenia, Australia, Austria, Bangladesh, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Columbia, Croatia, Czech Republic, Dominican Republic, Egypt, Estonia, France, Germany, Greece, Guatemala, Hungary, India, Indonesia, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kenya, Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Moldova, Montenegro, Morocco, Netherlands, New Zealand, Norway, Pakistan, Panama, Paraguay, Philippines, Poland, Portugal, Qatar, Republic of Yemen, Romania, Saudi Arabia, Senegal, Serbia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Tunisia, Turks and Caicos, Turkey, Uganda, United Arab Emirates, United Kingdom, and Uruguay.
- Lot
- lots 43827UQ12, 43819UQ03, 44449UQ05, 44127UQ06, 44334UQ07, 43994UQ07, 44596UQ08, 44775UQ09, and 44930UQ11.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAlinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in blood donorAugust 18, 2021
- FDAARCHITECT C System Mixer - Product Usage: The ARCHITECT Clinical Chemistry System is designed to performApril 15, 2020
- FDAC4 is an in vitro diagnostic assay for the quantitative determination of C4 in human serum or plasma. AntigenJuly 31, 2019
- FDAARCHITECT c4000 part number 02P24; ARCHITECT c8000 part number 01G06; ARCHITECT c16000 part number 03L77November 29, 2017
- FDAADVIA Centaur Calibrator C-Used with the ADVIA Centaur Ferritin assay on the ADVIA Centaur CP system only.November 5, 2014
- FDAAcrobat V Vacuum Off-Pump System OM-9100S Acrobat SUV Vacuum Off-Pump System OM-9000S Axius Xpose 3 AccessNovember 5, 2014
Questions about this recall
Was Lipase Reagent, 7D80. Used to measure lipase in human serum on the Architect system. recalled?
Yes. FDA published recall Z-0131-2015 on November 5, 2014. Reported hazard: Package inserts have incorrect SmartWash parameters for Triglyceride.
What should I do if I have this product?
Voluntary: Firm initiated · Letter